CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04173962
NCT04173962Phase 2Completed
CompareCT.gov

Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects: A Proof-of-Concept Translational Study

Icahn School of Medicine at Mount Sinai·interventional·Posted Nov 22, 2019·Updated May 10, 2022

In Brief

A Phase 2 clinical trial evaluating Ketamine and Midazolam for Healthy Volunteers. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The objective of this study is to examine the effect of a single IV dose of ketamine (0.5 mg/kg) on laboratory-induced stress in healthy participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedNov 22, 2019
Enrollment StartAug 8, 2019
Primary CompletionMar 18, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.6 years ago

Interventions

Ketaminedrug

administered 1 week prior to a laboratory-induced stress

Midazolamdrug

administered 1 week prior to a laboratory-induced stress